Antiretroviral Drug Resistance: Mechanisms, Pathogenesis, Clinical Significance

Adv Exp Med Biol. 1996;394:383-95. doi: 10.1007/978-1-4757-9209-6_35.

Abstract

The contribution of HIV drug resistance to treatment failure, the relationship of drug resistance to pathogenesis and the impact of resistance in the role of the promising new class of protease inhibitors remain areas of active investigation. A more precise understanding of these aspects of antiretroviral drug resistance will permit the more effective use of available drugs and the design of new drugs and drug regimens.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Antiviral Agents / pharmacology*
  • Antiviral Agents / therapeutic use*
  • Drug Resistance, Microbial / genetics
  • HIV Infections / drug therapy
  • HIV Infections / virology
  • HIV Protease Inhibitors / pharmacology
  • Humans
  • Retroviridae / drug effects*
  • Retroviridae / genetics
  • Retroviridae Infections / drug therapy*
  • Retroviridae Infections / pathology
  • Retroviridae Infections / virology
  • Reverse Transcriptase Inhibitors / pharmacology

Substances

  • Antiviral Agents
  • HIV Protease Inhibitors
  • Reverse Transcriptase Inhibitors